Genzyme's manufacturing plant cleared in US
This article was originally published in Scrip
Executive Summary
Genzyme (Sanofi) has finally obtained US approval for its manufacturing plant in Framingham, Massachusetts, for the production of Fabrazyme (agalsidase beta). This follows approval by the European Medicines Agency (EMA) last week.